Commonwealth Equity Services’s Meridian Bioscience Inc VIVO Stock Holding History

Commonwealth Equity Services’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-6,626	Closed	-$220K	–	3915
2022 Q4	$220K	Buy	+6,626	New	+$213K	﹤0.01%	3138
2021 Q3	–	Sell	-9,361	Closed	-$207K	–	3699
2021 Q2	$207K	Buy	+9,361	New	+$199K	﹤0.01%	3243
2018 Q2	–	Sell	-12,812	Closed	-$181K	–	2825
2018 Q1	$181K	Buy	12,812 +253	+2%	+$3.74K	﹤0.01%	2435
2017 Q4	$176K	Sell	12,559 -523	-4%	-$7.66K	﹤0.01%	2414
2017 Q3	$187K	Sell	13,082 -753	-5%	-$10.8K	﹤0.01%	2309
2017 Q2	$218K	Buy	+13,835	New	+$199K	﹤0.01%	2160

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Commonwealth Equity Services's VIVO Position: Q1 2023 in Review

Commonwealth Equity Services sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 6,626 shares — an estimated $220K sold.

Commonwealth Equity Services first reported a position in VIVO in Q2 2017 and held it in 6 quarters. The position peaked at $220K in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

Commonwealth Equity Services reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
Commonwealth Equity Services sold 6,626 Meridian Bioscience Inc shares in Q1 2023, an estimated $220K.
Commonwealth Equity Services first reported a position in Meridian Bioscience Inc in Q2 2017 and held it in 6 quarters.
Commonwealth Equity Services's Meridian Bioscience Inc position peaked at $220K in Q4 2022.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Commonwealth Equity Services's 13F filing for Q1 2023, filed 11 May 2023.